17 The retrospective study found that subcutaneous semaglutide use was statistically significantly associated with the risk of developing NAION, no matter what the medications reason for use: patients with type 2 diabetes had a 4.28 HR compared to control (n=17 vs 6), while patients who used the medications for weight loss had a 7.64 HR compared to control (n=20 vs 3)
Additionally, unlike male birds, female birds treated with BSO during development exhibited longer telomeres, increased growth, and greater body mass than control females in adulthood [45]
This means they are far more sensitive to these drugs in a way that humans generally are not
At Mullally Sports and Family Medicine, our professional team takes a personalized approach to weight loss care by evaluating each patients health history, goals, and treatment needs before recommending semaglutide GLP-1
The same is true for tirzepatide
Inject on the same day each week, at roughly the same time